Lilly (LLY) Completes Acquisition of Morphic Aug 16, 2024 08:39AM
TD Cowen Downgrades Morphic Therapeutic (MORF) to Hold Jul 9, 2024 07:28AM
RBC Capital Downgrades Morphic Therapeutic (MORF) to Sector Perform Jul 9, 2024 03:18AM
BMO Capital reiterates Eli Lilly (LLY) at Outperform on Morphic deal, 'a positive for Lilly shares' Jul 8, 2024 12:29PM
Morphic Therapeutic (MORF) option implied volatility into acquire Morphic for $57 per share Jul 8, 2024 07:17AM


Jul 8, 2024 06:48AM Eli Lilly & Co. (LLY) to Acquire Morphic (MORF) for $57/sh Cash or $3.2B